ALL Clinical Trials

62 clinical trials for ALL across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL — RECRUITING · PHASE1
• Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients — RECRUITING · PHASE1
• Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia — RECRUITING · PHASE1
• Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution — RECRUITING
• UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy — RECRUITING · PHASE1
• A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Kinetics of Universal Car-t Cell Injection in CD19 and / or CD20 Positive Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia in Adolescents, Children and Adults — RECRUITING · PHASE1
• Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders — RECRUITING · PHASE2
• Amish/Mennonite Research Contact Registry — RECRUITING
• Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation — RECRUITING · NA
• A Multicenter Study of CAR-T Cells in Primary Ph+All — RECRUITING · PHASE2
• Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL — RECRUITING · PHASE2
• A Long Term Follow-up Study of TScan TCR-T Products — RECRUITING
• Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies — RECRUITING · PHASE1
• Optical Genome Mapping in Hematological Malignancies — RECRUITING
• PRAISE-IR Versus CIBMTR Controls — NOT_YET_RECRUITING
• A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant — ACTIVE_NOT_RECRUITING · PHASE2
• Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies — COMPLETED · PHASE1
• Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer — ACTIVE_NOT_RECRUITING · NA
• my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults — NOT_YET_RECRUITING · NA
• Venetoclax Plus Inotuzumab for B-ALL — ACTIVE_NOT_RECRUITING · PHASE1
• A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19 — ACTIVE_NOT_RECRUITING
• Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults — COMPLETED
• Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies — TERMINATED · PHASE1
• Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia — NOT_YET_RECRUITING · NA
• Haplo Peripheral Blood Sct In GVHD Prevention — COMPLETED · PHASE1
• A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives — TERMINATED · PHASE2
• Family History in a Singaporean Healthy Population — COMPLETED
• Project Baseline Health Study — ACTIVE_NOT_RECRUITING
• Haploidentical Donor vs mMUD in Hematological Malignancies — COMPLETED · PHASE2
• Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders — TERMINATED · PHASE1
• Subjective treatment priority and health literacy: a cross-sectional survey — OTHER
• GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL — OTHER · PHASE1
• Patient Satisfaction in the Orthopedic Surgery Clinic — WITHDRAWN · NA
• commd7 Gene Expression in ALL — OTHER
• ACL Reconstruction With/Without ALL Reconstruction — OTHER · NA
• Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy — OTHER
• Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia — OTHER · PHASE2
• Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia — TERMINATED · PHASE1
• Risk of Osteoarthritis of the Knee at Least 5 Years After ACL Reconstruction: Comparative Study Between an Isolated ACL Reconstruction and a Reconstruction Combining ACL and ALL — OTHER · NA
• Prediction of Excretion and Toxicity of High Dose Methotrexate in Children and Adolescents With ALL — COMPLETED · NA
• Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma — COMPLETED · PHASE1
• Preventing Stem Cell Transplant Complications With a Blood Separator Machine — COMPLETED · PHASE1
• Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies — COMPLETED · PHASE1
• Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT — COMPLETED · PHASE2
• Collaborative Network to Take Responsibility for Oral Anticancer Therapy — OTHER · NA
• POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients — COMPLETED · PHASE1
• Understanding Methotrexate Induced Gastrointestinal Intolerance in Juvenile Idiopathic Arthritis and Childhood Leukemia — COMPLETED
• Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD — COMPLETED · PHASE2
• Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL) — COMPLETED · PHASE2
• Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders — COMPLETED · PHASE2

Refine this search